Table 1.
LOINC Axes | Fine Entity Types | Example Values |
---|---|---|
Component | Covid19 | “COVID-19,” “SARS-COV-2” |
Covid19_Related | “SARS-related CoV,” “SARS-like CoV” | |
RNA_Comp | “RNA,” “N gene,” “RdRp gene” | |
Sequence_Comp | “Whole genome” | |
Antigen_Comp | “Ag,” “Antigen” | |
Growth_Comp | “Organism” | |
Antibody_Comp | “Ab,” “Antibody,” “IgM,” “IgG” | |
Interpretation_Comp | “Interpretation,” “Recent infection” | |
System | Blood | “Blood,” “Serum,” “Plasma” |
Respiratory | “NARES,” “NASAL MUCUS” | |
NP | “NP,” “Swab,” “NASOPHARYNX” | |
Saliva | “SALIVA,” “ORAL FLUID” | |
Other | “UNSPECIFIED,” “UNKNOWN SPECIMEN” | |
Method | RNA_Method | “Non-probe-based,” “NAA,” “PCR” |
Sequence_Method | “Sequencing” | |
Antigen_Method | “Rapid IA,” “Immunoassay,” “IA” | |
Growth_Method | “Organism specific culture” | |
Antibody_Method | “Rapid IA,” “Immunoassay,” “IA” | |
Panel_Method | “Panel,” “Panl” | |
Quantitative_Qualitative | Quantitative | “Cycle Threshold,” “viral load” |
Qualitative | “Presence,” “Ord” | |
Institution | Manufacturer | “Abbott” |
COVID-19: coronavirus disease 2019.